Gelonghui, January 25丨According to the Stock Exchange's latest equity disclosure data, on January 20, 2024, Lee's Pharmaceuticals (00950.HK) received an increase of 90,000 shares by Executive Director Lee Ye-ni at an average price of HK$13,693 per share on the market, involving approximately HK$123,200.
After increasing her holdings, Lee Ye-ni's latest shareholding was 126,865,125 shares, and the shareholding ratio increased from 21.53% to 21.55%.
